Tumor necrosis factor-like cytokine 1A plays a role in inflammatory bowel disease pathogenesis

Fanxiang Meng,Xuefeng Jiang,Xiao Wang,Qianqian Zheng,Xiaonan N. Wang,Chenxue Mei,Siqi Yan,Yuting He,Junxiu Xue,Xiaoqing Zhang,Wenda Fu,Yong You,Jingbo Zhai,Yuanyuan Wang,Xun Sun

DOI: https://doi.org/10.1073/pnas.2120771120

2023-01-01

Abstract:The binding of tumor necrosis factor-like cytokine 1A (TL1A) to death receptor 3 (DR3) plays an important role in the interaction between dendritic cells (DCs) and T cells and contributes to intestinal inflammation development. However, the mechanism by which DCs expressing TL1A mediate helper T (Th) cell differentiation in the intestinal lamina propria (LP) during the pathogenesis of inflammatory bowel disease remains unclear. In this study, we found that TL1A/DR3 promoted Th1 and Th17 cell differentiation in T-T and DC -T cell interaction-dependent manners. TL1A-deficient CD4+ T cells failed to polarize into Th1/Th17 cells and did not cause colonic inflammation in a T cell transfer colitis model. Notably, TL1A was located in the cytoplasm and nuclei of DCs, positively regulated the DC-specific ICAM-grabbing nonintegrin/RAF1/nuclear factor kappa B signaling pathway, enhanced the antigen uptake ability of DCs, and promoted TLR4-mediated DC activation, inducing naive CD4+ T cell differentiation into Th1 and Th17 cells. Our work reveals that TL1A plays a regulatory role in inflammatory bowel disease